Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Gupta, Gaurav K ^a   Agrawal, Tanupriya ^a   Del Core, Michael G ^a   Hunter, William J ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCITRIOL; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; NEOINTIMAL LESION; NONHUMAN; PROTEIN EXPRESSION; RESTENOSIS; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; VITAMIN D DEFICIENCY;

ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CALCITRIOL; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HYPERPLASIA; LIPIDS; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, CALCITRIOL; RNA, SMALL INTERFERING; SUS SCROFA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

SUIDAE; SUS;

EID: 84864650303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042789     Document Type: Article

References (33)

1. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. ((2007)) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453.
2. Toutouzas K, Colombo A, Stefanadis C, ((2004)) Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25: 1679-1687.
3. Garg P, Cohen DJ, Gaziano T, Mauri L, ((2008)) Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol 51: 1844-1853.
4. Donners MM, Daemen MJ, Cleutjens KB, Heeneman S, ((2003)) Inflammation and restenosis: implications for therapy. Ann Med 35: 523-531.
5. Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, et al. ((2005)) Tumor necrosis factor-alpha plays an important role in restenosis development. FASEB J 19: 1998-2004.
6. Zhou Z, Lauer MA, Wang K, Forudi F, Zhou X, et al. ((2002)) Effect of anti-tumor necrosis factor-alpha polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model. Atherosclerosis 161: 153-159.
7. Nagpal S, Na S, Rathnachalam R, ((2005)) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687.
8. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, et al. ((2008)) Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93: 3927-3935.
9. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. ((2008)) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
10. Chen S, Law CS, Gardner DG, ((2010)) Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity. J Steroid Biochem Mol Biol 118: 135-141.
11. Hewison M, ((2010)) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39: 365-379 table of contents.
12. Somjen D, Weisman Y, Kohen F, Gayer B, Limor R, et al. ((2005)) 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111: 1666-1671.
13. Gupta GK, Dhar K, Del Core MG, Hunter WJ 3rd, Hatzoudis GI, et al. ((2011)) Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention. Exp Mol Pathol 91: 346-352.
14. Jia G, Mitra AK, Cheng G, Gangahar DM, Agrawal DK, ((2007)) Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits. J Surg Res 142: 137-142.
15. Shah PK, ((2003)) Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation 107: 2175-2177.
16. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, et al. ((2009)) Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 119: 3198-3206.
17. Seol SH, Kim DI, Han YC, Kim KH, Kim DK, et al. ((2009)) Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm. Korean Circ J 39: 439-442.
18. Williams S, Malatesta K, Norris K, ((2009)) Vitamin D and chronic kidney disease. Ethn Dis 19: S5-8-11.
19. Carlberg C, Quack M, Herdick M, Bury Y, Polly P, et al. ((2001)) Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues. Steroids 66: 213-221.
20. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE, ((2007)) VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. J Cell Biochem 100: 1395-1405.
21. Steele PM, Chesebro JH, Stanson AW, Holmes DR, Dewanjee MK, et al. ((1985)) Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 57: 105-112.
22. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, et al. ((1990)) Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 82: 2190-2200.
23. Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J, ((1997)) Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17: 490-497.
24. Halloran BP, DeLuca HF, ((1981)) Appearance of the intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal development in the rat. J Biol Chem 256: 7338-7342.
25. Dokoh S, Donaldson CA, Haussler MR, ((1984)) Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor. Cancer Res 44: 2103-2109.
26. Michos ED, Melamed ML, ((2008)) Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11: 7-12.
27. Carrelli AL, Walker MD, Lowe H, McMahon DJ, Rundek T, et al. ((2011)) Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 42: 2240-2245.
28. Cardus A, Gallego C, Muray S, Marco MP, Parisi E, et al. ((2003)) [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]. Nefrologia 23 Suppl 2: 117-121.
29. Rajasree S, Umashankar PR, Lal AV, Sarma PS, Kartha CC, ((2002)) 1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. Life Sci 70: 1777-1788.
30. Mitsuhashi T, Morris RC, Ives HE, ((1991)) 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 87: 1889-1895.
31. Wu-Wong JR, Nakane M, Ma J, Ruan X, Kroeger PE, ((2006)) Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis 186: 20-28.
32. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW, ((1997)) Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96: 3555-3560.
33. Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS, ((1998)) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors. Mol Cell Endocrinol 141: 65-72.